It has been previously shown in Tunisian and Algerian families that the locus for SCARMD maps to the proximal part of 13q, and in Algerian families that the disease is associated with deficiency of the 50 kDa dystrophin associated glycoprotein (SODAG). We have tested this linkage in six families from Morocco where this disease is also prevalent. In one family the 50DAG was tested and found to be negative in a muscle biopsy. Our results showed similar linkage in this country, with statistical tests indicating genetic homogeneity between the three Maghreb countries.
Abstract
It has been previously shown in Tunisian and Algerian families that the locus for SCARMD maps to the proximal part of 13q, and in Algerian families that the disease is associated with deficiency of the 50 kDa dystrophin associated glycoprotein (SODAG). We have tested this linkage in six families from Morocco where this disease is also prevalent. In one family the 50DAG was tested and found to be negative in a muscle biopsy. Our results showed similar linkage in this country, with statistical tests indicating genetic homogeneity between the three Maghreb countries. In the present study we have selected for linkage analysis six well characterised families from Morocco, comprising 18 patients (10 males and eight females) (figure). They were selected on the following obligate criteria: (1) a clinical and pathological pattern typical of SCARMD1 2; (2) multiplex families with at least one female affected. In addition the diagnosis was further validated by finding 50DAG deficiency by immunofluorescence analysis of one muscle specimen578 (patient 8 of family 4, figure) . The SCARMD families were genotyped using the following microsatellite markers assigned to the proximal long arm of chromosome 13: D13S221 (AFM 248wcl)9 D13S175 (AFM2 49xbl),9 and D 13SI 15,'°as described in Azibi et al. 6 The cumulated two point lod scores" obtained with the three markers in the six families and a comparison with the data obtained in 13 
